ID   RCDMD
AC   CVCL_9W53
DR   Wikidata; Q54949482
RX   Patent=US8337829;
RX   PubMed=7520531;
RX   PubMed=20395455;
CC   Doubling time: ~3 days (PubMed=7520531).
CC   Transformant: Unknown product of UCHT1 (Cellosaurus=CVCL_9W35) conditioned media.
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   7Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
RX   Patent=US8337829;
RA   Freeman T.B., Caviedes P., Caviedes R.;
RT   "Conditioned medium and proliferated cell lines produced therefrom.";
RL   Patent number US8337829, 25-Dec-2012.
//
RX   PubMed=7520531; DOI=10.1002/mus.880170909;
RA   Caviedes R., Caviedes P., Liberona J.L., Jaimovich E.;
RT   "Ion channels in a skeletal muscle cell line from a Duchenne muscular
RT   dystrophy patient.";
RL   Muscle Nerve 17:1021-1028(1994).
//
RX   PubMed=20395455; DOI=10.1096/fj.09-152017;
RA   Cardenas C., Juretic N., Bevilacqua J.A., Garcia I.E., Figueroa R.,
RA   Hartley R., Taratuto A.L., Gejman R., Riveros N., Molgo J.,
RA   Jaimovich E.;
RT   "Abnormal distribution of inositol 1,4,5-trisphosphate receptors in
RT   human muscle can be related to altered calcium signals and gene
RT   expression in Duchenne dystrophy-derived cells.";
RL   FASEB J. 24:3210-3221(2010).
//